针对兰格汉斯细胞的蛋白质递送增强了抗原特异性细胞免疫反应
Ramona Rica1, Klara Klein1, Litty Johnson1
1Cutanos GmbH, Josef-Holaubek-Platz 2 (UZA 2), 1090 Vienna, Austria.
概括
使用糖仿性分子的向抗原递送通过向兰格汉斯细胞 (LCs) 提高了疫苗的疗效. 这种方法提高了T细胞的反应,显示了下一代疫苗和免疫疗法的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 纳米技术 纳米技术
背景情况:
- 向免疫细胞,特别是树突细胞提供向的抗原是提高疫苗疗效和减少副作用的关键策略.
- 朗格汉斯细胞 (LCs) 是一种专门的树突细胞,表达表面受体朗格林,使它们成为抗原递送的有吸引力的标.
研究的目的:
- 通过Langerin研究一种新型糖相仿分子的使用,以便通过Langerin向LC提供蛋白质抗原.
- 评估兰杰林介导的抗原输送对体内免疫反应的影响.
主要方法:
- 开发和利用一个设计用于LCs上的朗格林受体选择性识别的小糖相仿分子.
- 给动物模型的蛋白质抗原与糖相对应分子结合.
- 免疫接种后对抗原特异性T细胞扩张和激活的评估.
主要成果:
- 通过使用糖相仿分子,成功地证明了蛋白质抗原到LC的特定传递.
- 与未经修改的抗原相比,兰杰林介导的抗原递送显著增强了免疫反应.
- 在免疫受试者中观察到抗原特异性T细胞扩张和激活的增加.
结论:
- 这项研究验证了一种针对LC的平台的可行性,用于用蛋白质抗原进行免疫细胞特异免疫.
- 临床连接器是开发先进疫苗和免疫疗法的宝贵接入点.
- 甘胺介导的向输送为下一代疫苗开发提供了一个有前途的战略.
更多相关视频
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.9K
13:18Artificial Antigen Presenting Cell aAPC Mediated Activation and Expansion of Natural Killer T Cells
Published on: December 29, 2012
18.6K
相关概念视频
Cell-mediated Immune Responses
83.5K
Overview
83.5K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Special Features of Adaptive Immunity
2.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.9K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
B Cell Activation and Differentiation
16.0K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.0K
